Introduction {#S1}
============

Mounting evidence shows the developing gut microbiome, particularly immediately after birth, plays an important role in human health^[@R1]--[@R3]^. Immune system maturation is orchestrated by early microbial exposures^[@R4],[@R5]^, and early childhood immune-mediated disorders including type 1 diabetes (T1D)^[@R6]^, asthma^[@R7]^, juvenile rheumatoid arthritis^[@R8]^, allergic disease^[@R9]^, and inflammatory bowel disease ^[@R10]^ are linked to aberrations in gut microbiota. Several human T1D cohort studies reported gut microbiota alterations^[@R11]^ and increased intestinal permeability^[@R12]^ prior to diagnosis, but mechanisms connecting gut health to autoimmune destruction of pancreatic beta cells remain relatively unknown. Complex relationships between the microbiome and the immune system^[@R13],[@R14]^ during the first years of life appear critical to later life health outcomes but have not been explored at the population scale.

Increasingly, microbiome-linked health outcomes appear to be consequences of individual strains of specific microbes^[@R15]--[@R17]^. These outcomes can result from structural variants in gene products of individual strains^[@R18]^, the presence or absence of gene cassettes^[@R19],[@R20]^ or currently unexplained mechanisms. Until recently, most culture-independent methods for investigating microbiomes in large-scale human populations (e.g., 16S rRNA gene amplicon sequencing) were limited in their resolution of distinct microbial strains. Now, efficient metagenomic sequencing and culture-independent strain-level analysis methods enable more detailed investigation of the early life microbiome.

Single-nucleotide polymorphisms (SNPs) accruing in microbial genomes over time can be used as a molecular clock to evaluate evolutionary distance between strains of the same species^[@R21]--[@R24]^. Such approaches have been instrumental in investigating maternal seeding of infant gut microbiomes^[@R23],[@R25]--[@R28]^. Complementing SNP-based methodologies, metagenomic assembly enables detecting and profiling known and previously unknown metagenomic species and genes, as well as gene content-based strain tracking^[@R16],[@R29]--[@R31]^. Gene-centric strain profiling also evaluates functional implications of strain-level variability more directly^[@R19],[@R20]^. While SNP- and assembly-based approaches successfully improved the resolution and clinical relevance of many population-level microbiome studies, comparisons of these complementary approaches on a single large microbiome dataset to identify subpopulations and functional adaptations has not been published.

For instance, bifidobacteria are widely-characterized beneficial commensals, commonly dominating the gut during breastfeeding and dissipating throughout life, that possess immunomodulatory functions, produce beneficial metabolites and metabolize a range of diet-derived, nondigestible carbohydrates^[@R32]^. Subspecies found specifically in the infant gut typically harbor a wide variety of genes enabling the sole use of human milk oligosaccharides (HMOs) for energy^[@R33]^. *B. longum* subsp. *infantis* (*B. infantis*)^[@R34]^ and some *B. longum* subsp. *longum* strains^[@R35]^ are capable of membrane transport and intracellular degradation of intact HMOs, whereas other *B. longum* subspecies rely partially on extracellular enzymes for HMO utilization^[@R36]^. Culture-independent detection of *B. infantis*, or any other *Bifidobacterium* strains, in metagenomic data is not well-established and requires the above-mentioned strain characterization methods.

Here, we characterize strain-specific genomic variation and its contribution to the early gut microbiome using an integrated and extended dataset from DIABIMMUNE, which includes nearly 300 children with human leukocyte antigen (HLA) haplotypes conferring increased risk to autoimmune disorders (roughly four-fold over the background population) in three neighboring countries: Finland, Estonia, and Russian Karelia. These children were observed for three years from birth by monthly stool sampling, frequent questionnaires about common life events and circumstances, and periodic blood sampling to track different immune parameters. The integrated DIABIMMUNE dataset consists of 16S rRNA gene sequencing of 3,204 samples and metagenomic sequencing of 1,154 samples, together spanning 289 subjects at an average of 11.4 (range 1-36) timepoints per subject. We briefly report association analyses of 16S data followed by SNP- and metagenomic assembly-based strain and pangenome analyses of common early gut species. The integrated DIABIMMUNE microbiome data provide detailed, strain-level characterizations of the developing gut microbiome.

Results {#S2}
=======

DIABIMMUNE followed Finnish, Estonian, and Russian children for three years from birth by collecting monthly stool samples, periodic serum samples, and frequent questionnaires on early life events. Here, we integrate all published DIABIMMUNE microbiome data generated in multiple studies using 16S rRNA amplicon, metagenomic and virome sequencing techniques^[@R37]--[@R40]^. After a unified quality control process, the data consisted of 3,204 16S amplicon and 1,154 metagenomic sequencing profiles from 289 and 269 subjects, respectively ([Table 1](#T1){ref-type="table"}, [Supplementary Figure 1](#SD2){ref-type="supplementary-material"}, [Supplementary Table 1](#SD3){ref-type="supplementary-material"}).

Early gut microbiome explorations are complicated by natural dynamics and numerous interactions with intrinsic and extrinsic factors. To further understand early microbial development relative to these factors, we analyzed 16S data using both omnibus and individual association tests. Early growth, household location and antibiotic courses during pregnancy, among other variables, were associated with early gut microbial composition ([Supplementary Note 1](#SD2){ref-type="supplementary-material"}, [Supplementary Figure 1](#SD2){ref-type="supplementary-material"}, **Supplementary Tables** [2](#SD6){ref-type="supplementary-material"}--[4](#SD8){ref-type="supplementary-material"}). Height at age three ([Supplementary Figure 1](#SD2){ref-type="supplementary-material"}) and growth rate during the first three years of life were positively associated with microbial diversity.

Strain diversity and ecology in the early gut {#S3}
---------------------------------------------

To expand the analysis beyond the genus level typical for 16S data, we leveraged shotgun metagenomic data to perform in-depth, strain-level analyses using SNPs and gene content. Strain analysis can delineate microbial sub-populations^[@R22],[@R41]^ and identify potential functional adaptations in the gut microbiome^[@R31]^. Particularly, *de novo* strain identification is important for species with a limited number of isolates, and the gut microbiome has many such understudied species despite large cultivation efforts^[@R42]^.

We first characterized dominant strains for the most abundant species in the metagenomic data by calling SNPs on conserved and unique species-specific marker genes selected from their core genomes (i.e., genes shared across all strains within the species)^[@R21]^. This resulted in a marker gene-based SNP haplotype of the dominant strain per species, hereby referred to as SNP haplotype. We then compared SNP haplotypes by sequence similarity and stratified them in intra- and inter-subject comparisons ([Fig. 1A](#F1){ref-type="fig"}, [Supplementary Figure 2](#SD2){ref-type="supplementary-material"}, [Supplementary Table 5](#SD9){ref-type="supplementary-material"}). Longitudinal, intra-subject comparisons showed more similar strains compared to inter-subject comparisons, as previously observed^[@R22],[@R43]^. We found a wide range of strain diversities among investigated bacterial species ([Fig. 1A](#F1){ref-type="fig"}, [Supplementary Table 5](#SD9){ref-type="supplementary-material"}): *Haemophilus parainfluenzae* and *Faecalibacterium prausnitzii* were among the most diverse species, with strains having less than 95% sequence similarity in SNP haplotype comparisons. Conversely, all investigated members of genus *Bacteroides* had very low sequence variability, with virtually identical SNP haplotypes in intra-subject comparisons (mean sequence similarity 99.96% over an average of 44.3kb of core genome per species) and over 99.6% sequence similarity on average in inter-subject comparisons. All other species analyzed had an average inter-subject similarity of 98.9%.

The observed high level of sequence identity in *Bacteroides* spp. contradicted existing evidence of diversity in their gene content^[@R44]^. We speculated that the SNP haplotypes did not capture all means of microbial genetic diversification, which include lateral gene transfer (LGT) and niche adaptation. Previously, we identified *Bacteroides dorei* as a highly abundant species potentially interfering with early immune maturation^[@R39]^. Therefore, we investigated genome diversity further in this species by isolating and sequencing eight *B. dorei* strains from human stool ([Supplementary Note 2](#SD2){ref-type="supplementary-material"}, [Supplementary Figure 2](#SD2){ref-type="supplementary-material"}, **Supplementary Tables** [6](#SD10){ref-type="supplementary-material"}--[7](#SD11){ref-type="supplementary-material"}). Each isolate genome harbored between 276 and 1,168 (median 750) unique accessory genes representing, on average, 13% of their genomes. Given the numbers of unique accessory genes across these *B. dorei* isolates, we wondered whether this diversity partially owed to LGT by bacteriophages.

Bacteriophages contribute to genome plasticity in *Bacteroides* spp. {#S4}
--------------------------------------------------------------------

*Bacteroides*-targeting bacteriophages (phages) are among the most common members of the highly diverse human gut virome, leading us to evaluate their contribution to the observed genome plasticity in this genus. To investigate bacteria-phage interactions in the gut, we utilized viral contigs (viromes) assembled using data from virus-like particle preparations of 22 DIABIMMUNE subjects^[@R40]^. Using bacterial metagenomes of subjects with viral contig data and a designated computational method^[@R45]^ ([Supplementary Note 3](#SD2){ref-type="supplementary-material"}), we reconstructed metagenomic CRISPR arrays that harbor spacer sequences targeting phages to which bacteria have adapted a response. We found the number of CRISPR spacers in the metagenomes reflected the microbiomes' increasing diversity and overall maturation ([Supplementary Figure 3](#SD2){ref-type="supplementary-material"}). In total, we identified 2,463 CRISPR spacers matching sequences in the gut virome across all samples, of which 223 matched sequences in the gut virome of the same subject ([Supplementary Figure 4](#SD2){ref-type="supplementary-material"}, [Supplementary Table 8](#SD12){ref-type="supplementary-material"}). We found 658 of these spacers in CRISPR cassettes on assembled metagenomes, covering 32 bacterial taxa, with *B. vulgatus* harboring the most (84, 28.5% of the spacers matching contigs annotated on species level), *B. dorei* harboring 9, and all *Bacteroides spp.* collectively harboring 138 spacer sequences ([Supplementary Table 9](#SD13){ref-type="supplementary-material"}). Additionally, when mapped against the virome, 105 (4.2%) spacers matched viral contigs annotated as *Bacteroides spp* phages. These data suggest *Bacteroides* spp. were exposed to an extensive phage repertoire in the children's guts, providing a plausible mechanism for increased genomic plasticity in *Bacteroides*.

Metagenomic assembly highlights strain diversification patterns within gut species {#S5}
----------------------------------------------------------------------------------

To explore accessory genome variation more broadly and across all taxa, we turned to *de novo* metagenome assembly of DIABIMMUNE metagenomes. This expanded the gene pool (number of observed non-redundant genes) to 6,328,944 gene families, compared to 1,932,010 gene families found using NCBI isolate genomes. Using a co-abundance technique^[@R30]^, we binned the assembled metagenomes into metagenomic species and constructed pangenomes for 22 species ([Fig. 1B, C](#F1){ref-type="fig"}).

Among all analyzed species, *Bacteroides* spp. and *E. coli* harbored the largest assembled pangenomes, each with over 25,000 genes ([Fig. 1C](#F1){ref-type="fig"}), consistent with high genome plasticity reported in these taxa^[@R44],[@R46]^. Consistent with the SNP haplotype analysis, strains recovered from the same individual were more similar to each other than to strains found in different individuals ([Fig. 1B](#F1){ref-type="fig"}, [Supplementary Table 5](#SD9){ref-type="supplementary-material"}). The magnitude of variability, however, was much higher for gene content than for SNP haplotypes ([Fig. 1A, B](#F1){ref-type="fig"}). These measures were highly correlated in most species but showed low or no correlation in a minor subset, including *F. prausnitzii* and *B. dorei* ([Fig. 1D](#F1){ref-type="fig"}). In *B. dorei*, the results from metagenomic assemblies and isolate genomes showed a similar trend, suggesting the incongruity between SNP haplotypes and assembled genomes was not an artefact of metagenomic assembly ([Fig. 1E](#F1){ref-type="fig"}). Rather, it indicates a more rapid or higher volume diversification in the accessory genome compared to the point mutation rate in the core genome. In contrast, *E. coli* metagenome assemblies displayed a high correlation between gene content and SNP haplotype similarities ([Fig. 1F](#F1){ref-type="fig"}) as previously reported^[@R47]^.

We again used the longitudinal nature of our study to compare the difference in gene content between strains from the same or different individuals. On average, *B. dorei* metagenomic assemblies had 88% gene content similarity in intra-subject comparisons and significantly lower (69%) similarity in inter-subject comparisons. Notably, these values are within the observed range comparing *B. dorei* isolate genomes ([Supplementary Figure 2](#SD2){ref-type="supplementary-material"}). *H. parainfluenzae*, an autochthonous oral cavity member, was an outlier with very similar intra- and inter-subject gene similarities (65% and 62%, respectively), conceivably reflecting transient gut colonization events and frequent replacement with new strains transmitted from the oral cavity. A closer investigation of colonization patterns for several common oral species in the guts of these children revealed that many such species bloomed in Finnish and Estonian infants during the first year of life ([Supplementary Note 4](#SD2){ref-type="supplementary-material"}, [Supplementary Figure 5](#SD2){ref-type="supplementary-material"}, [Supplementary Table 10](#SD4){ref-type="supplementary-material"}).

Strain-level variation in *Bifidobacterium* spp. reflects breastfeeding patterns and geography {#S6}
----------------------------------------------------------------------------------------------

Our strain diversity analysis identified relatively high intra-subject variability in *B. longum* compared to other common *Bifidobacterium* species *B. bifidum* or *B. breve* ([Fig. 1A, B](#F1){ref-type="fig"}). Given implications of bifidobacteria in immune development and early microbial community assembly^[@R2],[@R48]^, we sought to explore in more detail the functional consequences of this strain-level variation during infancy. To first identify a known *B. longum* subspecies clade, *B. infantis*, we surveyed the metagenomic data for genes of a well-characterized *B. infantis* cluster responsible for HMO transport and degradation^[@R34]^. Presence of these genes corresponded with the SNP haplotype-based phylogeny of *B. longum* strains ([Fig. 2A, B](#F2){ref-type="fig"}) and two *B. infantis* reference sequences (ATCC 15697) clustered with 70 strains harboring these genes (highlighted red in [Fig. 2A](#F2){ref-type="fig"}). We found evidence of this gene cluster in 14 additional samples, which possibly harbored multiple *B. longum* strains, of which *B. infantis* was non-dominant, and resulted in a SNP haplotype profile not based on *B. infantis*.

*B. infantis* was found in 23.7% (42/177) of stool samples collected during breastfeeding but only 3.2% (11/343) of samples collected after weaning (excluding samples with low relative abundance of *B. longum* precluding strain identification and samples from subjects with no breastfeeding information), reflecting a clear strain shift relative to breastfeeding cessation. Overall, 10% of Finns, 20% of Estonians and 23% of Russians harbored *B. infantis* in at least one stool sample (either during breastfeeding or after cessation), suggesting that most subjects in this cohort never obtained *B. infantis* in their gut ecosystems. Comparing *B. infantis* with other *B. longum* strains revealed evidence of a competitive advantage, conferred by the HMO gene cluster or other genomic differences, that allows *B. infantis* to reach higher relative abundances on average ([Fig. 2B](#F2){ref-type="fig"}), albeit with modest effect sizes.

Probiotics supplements and foods containing commercial strains of *Bifidobacterium* spp. are also a common source of bifidobacteria in early life. One such species, *B. bifidum*, showed contrasting relative abundances between the countries: unlike Finnish and Estonian samples, Russian samples commonly contained over 10% of *B. bifidum* ([Fig. 2C](#F2){ref-type="fig"}). *B. bifidum* SNP haplotypes revealed that 79 samples from 34 Russians, 3 Estonians, and 2 Finns harbored the same *B. bifidum* strain with greater than 99.9% sequence similarity ([Fig. 2D](#F2){ref-type="fig"}). This SNP haplotype was identical to the NCBI isolate genome *B. bifidum* 791, which was isolated from a healthy human gut in Nizhny Novgorod, Russia and has been patented for medical use in Russia. *B. bifidum* relative abundance was over 10% in 57 of 79 (75%) samples containing this strain. While these observations are not direct evidence for engraftment of this strain, they show that a probiotic strain can obtain high (\>50%) relative abundance in the infant gut.

Contributional diversity of microbial functions {#S7}
-----------------------------------------------

Finally, we approached the developing microbiome from a function-centric view^[@R49]^. We binned species based on shared functional pathways and assessed their contributional diversity (i.e., how diverse sets of species encode and have a potential to perform a given function per sample)^[@R49]^ for 365 Gene Ontology (GO) biological process terms present in over 100 metagenomes. Most GO terms displayed increasing within-sample functional diversity (Gini-Simpson index) with increasing age that coincides with microbiome maturation and increasing taxonomic diversity ([Fig. 3A](#F3){ref-type="fig"}, [Supplementary Table 11](#SD5){ref-type="supplementary-material"}). Many widely distributed pathways such as sporulation (GO:0030435), glycolysis (GO:0006096) and riboflavin biosynthesis (GO:0009231) followed this pattern. Contrastingly, a few specific pathways displayed the opposite trend: aerobic electron transport chain (r=−0.16, q=0.001, GO:0019646), viral release from host cell (r=−0.05, q=1.0, GO:0019076) and siderophore biosynthetic process (r=−0.07, q=1.0, GO:0015891) showed decreasing or stable functional diversity within samples over time ([Fig. 3A](#F3){ref-type="fig"}, [Supplementary Table 11](#SD5){ref-type="supplementary-material"}).

Between-sample contributional diversities (beta-diversity, Bray-Curtis dissimilarity) reflect the stability of functional contributions per pathway and can be assessed longitudinally within and across subjects. We observed a decreasing longitudinal trend in contributional beta-diversities with increasing age ([Fig. 3B](#F3){ref-type="fig"}, correlation between age and beta-diversity, Pearson r=−0.28, p\<2.2e-16), reflecting a change towards a more stable, adult microbial composition. Microbial contributions to pathways were more stable within individuals (Student's *t*-test p\<1e-20 in all time windows), as reflected by lower beta-diversities, and the gap between intra- and inter-subject comparisons tended to widen with time, similar to the average beta-diversities of taxonomic profiles ([Fig. 3B](#F3){ref-type="fig"}). This provides another perspective of early stabilization of gut microbial communities: as pathways in some cases reflect ecological niches (e.g., aerobic electron transport), the above trend may mirror convergence to specific ecological attractor states, which in turn results in stabilization after community adaptation and competition over the niche has resolved ([Fig. 3B](#F3){ref-type="fig"}).

Pathways related to bacterial acquisition of iron by siderophores ([Fig. 3A](#F3){ref-type="fig"}) provide an example interpreting contributional diversities^[@R49]^. Bacteria secrete iron-binding siderophores to harvest iron, but extracellular siderophores are exploited by other bacteria. According to the black queen hypothesis, the ability to produce such costly but necessary molecules is under negative selection until the production is minimal but sufficient to support the microbial community^[@R50]^. Indeed, according to our data, a single dominant species per community contributes to siderophore biosynthesis (i.e., low contributional alpha-diversity, [Fig. 3A, C](#F3){ref-type="fig"}), whereas siderophore transport-related genes are more widely distributed across community members ([Fig. 3A, D](#F3){ref-type="fig"}).

Discussion {#S8}
==========

Here, we report a longitudinal, strain-level investigation of the developing gut microbiome utilizing the DIABIMMUNE cohort and its rich metadata of various life events. We integrated all published microbiome data, resulting in 3,204 16S amplicon and 1,154 metagenomic sequencing profiles from 289 and 269 subjects, respectively. This integrated dataset will serve as a reference resource for the microbiome research community. Further, our analyses contribute to taxonomic and functional understandings of early gut communities.

A strain can be defined experimentally --- a single clonal isolate --- or operationally --- a combination of variants detected in a metagenomic assembly, phased haplotype, or collection of reads --- as used here. SNP and gene content profiling offer complementary means of tracking microbial strains in metagenomic data. While metagenomes can provide information on many strains simultaneously, depth of resolution on any one strain is limited. SNP-based methods usually operate within a few percentages of each genome that serves as a marker region for evaluating evolutionary distance within a population^[@R21]--[@R24]^. Evaluating the gene content of microbial strains offers more direct means for functional interpretation of any observed differences^[@R19],[@R20]^. For most species, these approaches provided highly concordant phylogenetic population structures, as evidenced by high correlation between SNP haplotype and gene content similarities. In some species such as *F. prausnitzii* and *B. dorei*, however, these measures did not correlate. *F. prausnitzii* is a phylogenetically diverse clade, consisting of distinct subspecies clades that blur the distinction between strain tracking and species differentiation and potentially confound the methodologies for tracking strains^[@R41]^. We isolated and sequenced eight high-quality *B. dorei* genomes that confirmed this observation. For these and similar species, such as *B. adolescentis* and *R. intestinalis*, the observed lack of correlation may stem from the difference between the time scales at which the measures operate; rapid genetic adaptation driven by promiscuous LGT and gene loss contrasted by slower, long-term SNP acquisition may confound the correlation^[@R51]^. The consequence of most of these adaptations for strain fitness or symbiosis with the host early in life, especially considering the known immunomodulatory effects of specific strains , remains to be elucidated.

This study contributes several observations on another group of bacteria common in early childhood, *Bifidobacterium*. We observed virtually identical *B. bifidum* strains in 79, mostly Russian, samples. This analysis demonstrates that microbial strains may be shared on the population level and such strain-level trends can be detected from metagenomic data. The observed strain, *B. bifidum* 791, has been patented for medical use in Russia (<http://russianpatents.com/patent/216/2165454.html>), and local regulation allows adding such bacterial components to infant formulas (GOST 30626-98 "Dry milk products for infant feeding" <http://gostexpert.ru/data/files/30626-98/0f82d40248598989307bf0a50b573429.pdf>). Our communication with locals confirmed this strain is common in baby formulas and other infant food products. Therefore, these 34 Russian infants potentially obtained this strain, which may achieve stable engraftment, as a probiotic supplement. This observation supports the idea that early gut microbial assembly can be intervened by probiotics^[@R48]^, which can confer beneficial effects such as restoration of healthy growth^[@R52]^ and protection against immune-mediated diseases^[@R53]^ or adverse effects of antibiotic courses^[@R54]^.

There are consequential differences in HMO processing capabilities within *Bifidobacterium* species that underscore the importance of identifying bacterial strains in this genus. We detected *B. infantis* in metagenomic data by both its HMO processing genes and SNP haplotype profile. We observed *B. infantis* in only 10% of Finns in this cohort, suggesting that this keystone species may be less prevalent in Finnish gut ecosystems. Among other effects, this may lead to elevated fecal pH levels, further promoting inflammation-favoring bacteria and gut dysbiosis^[@R55]^. A probiotic trial adding *B. infantis* to breast milk during the first weeks of life demonstrated persistent *B. infantis* engraftment and beneficial alterations in intestinal fermentation^[@R48]^. Our data corroborates the notion that intracellular HMO utilization provides *B. infantis* a competitive advantage over other HMO-consuming species, allowing *B. infantis* to dominate the infant gut during breastfeeding. Based on these findings and literature (reviewed by Insel and Knip^[@R56]^), we hypothesize that natively resident or supplemented *B. infantis* during breastfeeding drives a shift in gut microbial community structure, shaping subsequent ecology and potentially immune development and/or protection against immune disorders in genetically predisposed populations. This could be tested by further characterization of the associated bifidobacterial functional diversity and by randomized, placebo-controlled clinical trials in humans.

Methods {#S9}
=======

DIABIMMUNE cohort {#S10}
-----------------

The DIABIMMUNE cohort recruitment took place between September 2008 and July 2011 in Finland, Estonia and Russia. Families with a newborn infant with HLA DR-DQ alleles conferring increased risk for autoimmunity, determined by a cord blood test, were invited to join the study. The parents gave their written informed consent prior to sample collection. The study participants were monitored for infections, use of antibiotics, breastfeeding, introduction of complementary foods, and other life events on study visits at months 3, 6, 12, 18, 24, and 36 from birth. Maternal information and events during the pregnancy were collected using a questionnaire on these visits. Serum samples were collected from all subjects during visits to the clinic at the following time points: 0 (cord blood), 3, 6, 12, 18, 24, and 36 months. Diabetes-associated autoantibodies were analyzed as previously described^[@R37]^. The DIABIMMUNE study was conducted according to the guidelines in the Declaration of Helsinki, and all procedures involving human subjects were approved by Ethical Committee for Psychiatric Diseases and Diseases in Children and Adolescents, Helsinki and Uusimaa Hospital District (Finland), Ethics Review Committee on Human Research of the University of Tartu (Estonia) and Ethical Committee, Ministry of Health and Social Development, Karelian Republic of the Russian Federation (Russia). More information about the cohort and data collection can be found in other DIABIMMUNE publications^[@R37]--[@R39]^ and online at <http://www.diabimmune.org/> and <https://pubs.broadinstitute.org/diabimmune/>.

For statistical association testing described below, the additional information (external variables) of subjects was preprocessed as follows. The external variables were categorized into two categories: generic and complex variables. Here, generic variable (maternal age at delivery, gestational diabetes, gestational age in days, mode of delivery, gender, country of birth, cohort, and HLA risk class) information was available for all subjects and contained no missing values. Complex variables, on the other hand, contained missing values and in many cases required pre-processing and exact defining beforehand (e.g., antibiotics courses, maternal illnesses during pregnancy, urban or rural family location when the child was born, daycare attendance, elder siblings, etc.). As breastfeeding information was not available for all the subjects and reduced the sample sizes significantly in cross-sectional analyses, it was not considered a generic variable. While the associations between the generic variables and the gut microbial communities were modeled together in one analysis, the associations of complex variables were determined by modeling them one-by-one with all generic variables.

16S sequencing analysis {#S11}
-----------------------

16S rRNA gene sequencing was conducted essentially as previously described^[@R57]^. Paired-end sequencing reads were demultiplexed using ea-utils command line tools (<https://code.google.com/p/ea-utils/>) and clustered into operational taxonomic units (OTUs) using the UPARSE pipeline^[@R58]^. Reads were quality-filtered using the UPARSE quality-filtering threshold of Emax=1, at which the most probable number of base errors per read is zero for filtered reads^[@R59]^. Filtered reads were trimmed to a fixed length, singletons removed, and clustered *de novo* into OTUs, with simultaneous chimera filtering. Taxonomic classification of OTUs was performed against the Greengenes version 13.8 16S rDNA database^[@R60]^. The full OTU table was filtered by removing samples with less than 3,000 OTU counts and by removing OTUs appearing in less than 5% of samples (178 samples). This resulted in an OTU table consisting of 3,204 samples from 289 subjects and 920 OTUs.

PERMANOVA analysis between the external variables and gut microbiomes were performed on 16S rRNA amplicon sequencing data of samples collected roughly at 2 (between 0 and 90 days), 6 (170 and 260 days) and 18 months (510 to 600 days) of age using adonis function in *vegan* R package (default parameters). Per each subject, the sample closest to the exact cross-section time under analysis was chosen, resulting in 140, 184 and 202 samples per time window, respectively. The order of external variables in the multivariable PERMANOVA model formula was determined by first analyzing each variable individually using univariable PERMANOVA model and then ordering the variables based on the significance of their association (i.e., permuted p-value) from the most to the least significant in the multivariable PERMANOVA model. Statistical significance of PERMANOVA results was evaluated by permutation test with 10,000 permutations.

Individual associations between bacterial genera and external variables were tested using MaAsLin, which conducts outlier removal, feature selection and linear modeling^[@R61]^. Association analyses were performed in both cross-sectional and longitudinal manners. The cross-sectional analyses were conducted on the same samples from the time windows chosen for the PERMANOVA analyses, where all variables of the analyses (only generic variables or generic and one added complex variable) were used as fixed effects. In the longitudinal analyses, subject IDs were used as a random effect, and all the generic variables and breastfeeding information were used as fixed effects. In the case a complex variable was added to the analysis, it was also used as a fixed effect. With these effect settings in longitudinal analyses, a total of 2,586 samples from 237 subjects were available, where the numbers varied according to the complex variable added to the analysis and the amount of missing values it introduced. For both the cross-sectional and longitudinal analyses, genus-level 16S rRNA microbiome data was used for identifying taxonomic level associations of the external variables.

Metagenomic sequencing {#S12}
----------------------

The metagenomic shotgun sequencing was conducted as previously described^[@R37]--[@R39]^. Additional sequencing data was generated for 45 samples which were excluded from a previous investigation^[@R39]^ due to low read count and are indicated in [Supplementary Table 1](#SD3){ref-type="supplementary-material"}. The quality control for the metagenomic shotgun sequencing data was conducted using kneadData v0.4.6.1 with additional automatic adapter detection and trimming at a minimum overlap of 5bp by Trim Galore!. Taxonomic profiles were generated using MetaPhlAn v2.6^[@R62]^ and functional profiling was done by HUMAnN2 v0.10.0^[@R49]^, which provides gene family level (here, 90% similarity) quantifications of microbial genes that are further stratified by contributing organisms. The gene families were further mapped to Gene Ontology (GO)^[@R63]^ terms as previously described^[@R39]^. Strain SNP haplotypes were generated using StrainPhlAn^[@R21]^ by requiring minimum coverage of 10 bases for SNP calling ("\--min_read_depth 10" command line parameter for sample2markers.py).

Metagenomic assembly {#S13}
--------------------

Metagenomic reads were assembled into contigs using MegaHIT^[@R64]^ individually for each sample, followed by an open reading frame prediction using Prodigal^[@R65]^. A non-redundant gene catalogue was constructed in a fashion similar to earlier approaches^[@R29]^ by clustering genes based on sequence similarity at 95% identity and 90% coverage of the shorter sequence using CD-HIT^[@R66]^. Subsequently, the gene catalogue was merged with the IGC gene catalogue^[@R67]^ using the same criteria to create a more comprehensive reference gene catalogue for the gut microbiome. Only genes detected in DIABIMMUNE samples (\~6M) were used in the downstream analysis. Gene abundance was estimated by mapping quality trimmed reads from each sample to the gene catalogue with BWA^[@R68]^. This served as an input for binning genes into metagenomic species using canopy clustering that finds core genes for each metagenomic species^[@R30]^. Metagenomic species with at least 400 genes were retained for further analysis. To extend the analysis beyond core genes, we detected accessory genes in each sample in which the metagenomic species was present in the following manner. We recruited genes co-assembled on the same contigs as core genes as long as the abundances of these genes was between the 10th and 90th percentiles of the abundances of core genes in a sample. Core genes and accessory genes grouped together in this manner across all samples defined the metagenomic pangenome of a species. To define a metagenomic strain, we used the same 10th and 90th percentiles of the abundances of core genes criteria to determine the specific accessory genes from the pangenome associated with the core genes of a metagenomic species in a sample. Similarity between pairs of metagenomic strains within species was measured using the percentage of shared genes in the smallest of the two genomes, as established previously^[@R47]^. Assembled genes were annotated with COG, KEGG and GO terms using eggnog mapper^[@R69]^ and at species, genus and phylum levels with NCBI RefSeq (version July 2017) as described previously^[@R67]^.

Phylogenetic trees {#S14}
------------------

Phylogenetic trees ([Fig. 2A, D](#F2){ref-type="fig"}, [Supplementary Figure 5](#SD2){ref-type="supplementary-material"}) were generated based on StrainPhlAn SNP haplotypes using the *phangorn* R package^[@R70]^. Briefly, similarities between strain haplotypes were computed using Jukes and Cantor (JC69) model, and an initial tree was constructed using UPGMA hierarchical clustering. The tree was optimized using maximum likelihood method, by iterative optimization of edge lengths, base frequencies and topology. Visualizations were generated using *ggtree* R package. For *Bifidobacterium bifidum* ([Fig. 2D](#F2){ref-type="fig"}), strains with \>99.5% sequence similarity were collapsed to a single tip and represented by the strain with the lowest average distance to other strains prior to optimizing the phylogenetic tree.

*B. dorei* isolate genomes {#S15}
--------------------------

*Bacteroides dorei* colonies were isolated from serial dilutions of DIABIMMUNE and PRISM (Prospective Registry in IBD Study at Massachusetts General Hospital) stool samples plated on selective and non-selective media after being incubated anaerobically at 37 °C for 72 hours. To isolate high molecular weight DNA for PacBio sequencing (Pacific Biosciences, Menlo Park, USA), the isolates were grown on brain heart infusion agar supplemented (sBHI) with 10% fetal bovine serum (Hyclone), 1% hemin/vitamin K solution (BD), 1% trace vitamins (ATCC), 1% trace minerals (ATCC), 0.5 g/L cysteine hydrochloride (Sigma), 1 g/L maltose, 1 g/L fructose (VWR), and 1 g/L cellubiose (Sigma) anaerobically at 37 °C for 72 hours. Colonies were transferred to 30 mL sBHI broth and grown anaerobically for 48 hours. Cells were centrifuged at 4,450 rpm for 10 minutes and supernatant was discarded. DNA was extracted using the Genomic-tip 500/G kit (Qiagen) according to the manufacturer's instruction. After isopropanol treatment, precipitated DNA was spooled and transferred to 70% ethanol 1.2 mL tube and left to dry in a clean PCR hood for 4 hours. Dried DNA was resuspended in elution buffer (Qiagen). DNA fragment size was measured with 4200 TapeStation (Agilent) using a Genomic DNA ScreenTape (Agilent). PacBio sequencing libraries were constructed by the blunt-ended ligation of SMRT bell adapter sequences to needle-sheared genomic DNA as per the manufacturer's instructions (Pacific Biosciences). The libraries were damage-repaired using the SMRTbell Damage Repair Kit (Pacific Biosciences) following the manufacturer's instructions and subsequently size-selected on a Blue Pippin with an 8 kb cut-off and then loaded on a Sequel sequencing instrument with MagBeads as per the manufacturer's instructions (Pacific Biosciences). The genomes were assembled using the internal PacBio assembler HGAP4. Reads less than 6 kb in length were excluded from the assembly process.

The assembled *B. dorei* genomes were analyzed using PanPhlAn^[@R71]^ (default settings) together with five existing isolate genomes in NCBI. The resulting non-redundant gene catalogue was annotated by translated DIAMOND search^[@R72]^ against the UniRef90 and UniRef50 databases and by enforcing UniRef's clustering criteria. We primarily used UniRef90 annotations, if available, but applied UniRef50 annotation in absence of UniRef90 annotation.

*B. longum* gene analysis {#S16}
-------------------------

*B. longum* HMO gene presence in the metagenomic samples ([Fig. 2A](#F2){ref-type="fig"}) was determined as follows. We identified UniRef90 gene families corresponding to the protein sequences in *B. infantis* HMO gene cluster^[@R34]^ (protein sequences Blon_2331-Blon_2361 in NCBI protein sequence database) by translated BLAST search against *B. longum* pangenome in ChocoPhlAn pangenome collection^[@R73]^ utilized by HUMAnN2. Specifically, we required ≥90% alignment identify and ≥80% mutual coverage (corresponding to the definition of UniRef90 gene families) and accepted only the best hit per protein sequence. Combining this information with HUMAnN2 species-stratified UniRef90 gene family quantification enabled calling these genes present given that they had sufficient read coverage, here defined as log~10~(counts-per-million / *B. longum* relative abundance) \> 1.

Contributional diversities of metagenomic functions {#S17}
---------------------------------------------------

Contributional diversities of the metagenomic functions were analyzed as previously described^[@R49]^. Briefly, stratified abundances of metagenomic functions were first renormalized after excluding any "unclassified" relative abundance. Contributional diversity for a given metagenomic function was then calculated by applying ecological similarity measures to the stratified abundance of that function. Gini-Simpson index was used for alpha-diversity and Bray-Curtis dissimilarity was used for beta-diversity.

CRISPR array detection and mapping {#S18}
----------------------------------

CRISPR spacers and repeat sequences were searched using Crass version 0.3.8^[@R45]^. We mapped all identified 42,412 CRISPR spacers sequences to viral contigs of 112 samples with viromic data using bowtie2 version 2.3.4.1^[@R74]^ using the parameters \`-N 1 \--local \--no-unal\` and exported results in bam format using \`samtools view -bS -\` with an overall alignment rate of 5.81% (2,463 aligned spacers). Alignment of the 42,412 spacers and 3,272 repeats against the full set of metagenomic assembled contigs (n=5,368,547) were performed with the same bowtie2 setting, resulting in an overall alignment rate of 73% and 95% for spacers and repeats, respectively. We determined the number of spacer and repeat matching the contigs of the DIABIMMUNE assembly and marked 658 spacers matching a virome contig in which also repeat matches were found. The majority of the repeats (93%) had multiple matches in the assembly, as expected for CRISPR repeats.

Data availability {#S19}
-----------------

All 16S rRNA and metagenomic sequencing data are available in NCBI Sequence Read Archive under BioProject PRJNA497734 and through the DIABIMMUNE microbiome website at <https://pubs.broadinstitute.org/diabimmune/>.

Code availability {#S20}
-----------------

The analysis software used for quality control and taxonomic and functional profiling is publicly available in bioBakery at <https://bitbucket.org/biobakery/biobakery/> and referenced as appropriate. More detailed analysis scripts will be made available upon request.
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![Strain diversity across species in early gut metagenomes.\
**A** SNP haplotype similarities per species based on all pairwise comparisons (dominant strain per species per sample) and stratified to intra-subject and inter-subject comparisons. Species containing \>10 comparisons in both strata are shown. **B** Gene content similarities (the percentage of shared genes in the smallest of the two genomes) per species, evaluated on pangenomes generated by metagenomic assembly. Boxplots as in panel **A**. The box (**A**, **B**) shows the interquartile range (IQR), the vertical line shows the median and the whiskers show the range of the data (up to 1.5 times IQR). Sample size (n) per boxplot in panel **A** gives number of comparisons per panels **A** and **B**. **C** The size of core and accessory genomes per species stratified by the functional annotation of genes using eggNOG. Panels **A-C** are ordered according to the size of the metagenomic pangenome. **D** Pearson's correlation coefficients between SNP- and gene content-based similarity measures between strains. Sample size (n) is indicated. **E** *B. dorei* strains' SNP and gene content similarities show low Pearson's correlation (r=0.2, n=8646 comparisons from metagenomes, n=136 comparisons of isolate genomes). Comparisons between isolate genomes are shown in orange for reference. **F** *E. coli* strains' SNP and gene content similarities (Pearson's r=0.88, n=16,110 comparisons).](nihms-1512780-f0001){#F1}

![Bifidobacterium strains in DIABIMMUNE children.\
**A** Phylogenetic tree of *B. longum* strains in DIABIMMUNE stool samples and 18 NCBI *B. longum* isolate genomes based on SNP haplotypes. Highlighted *B. infantis* strains (red) include two reference sequences (ATCC 15697). The heatmap illustrates strain-specific carriage of 21 genes in the *B. infantis* HMO gene cluster responsible for intracellular HMO degradation, evaluated using the metagenomic data. **B** *B. longum* relative abundance stratified by country and *B. longum* strain; *B. infantis* (highlighted red in panel **A**) has, on average, higher relative abundance compared to other *B. longum* strains (mixed effects logistic regression p=0.00049). The box shows the interquartile range (IQR), the vertical line shows the median and the whiskers show the range of the data (up to 1.5 times IQR). Number of samples (n) are indicated below each box and include samples from subjects with no breastfeeding information. **C** Relative abundance of *B. bifidum* longitudinally stratified by the countries up to 24 months of age (n = 864). Russians have more *B. bifidum*, especially during the first year of life. The curves show locally weighted scatterplot smoothing (LOESS) fits for the relative abundances, and shaded areas show 95% confidence interval for each fit, as implemented in geom_smooth function in ggplot2 R package. **D** Phylogenetic tree of *B. bifidum* strains in the DIABIMMUNE stool samples based on SNP haplotypes. Strains with \>99.5% sequence similarity have been collapsed into a single tip. A known strain, *B. bifidum 791*, was found in 79 stool samples. The scale bars on phylogenetic trees denote difference in sequence similarity of SNP haplotypes.](nihms-1512780-f0002){#F2}

![Contributional diversity of microbial pathways.\
**A-B** We applied alpha- (**A**) and beta-diversity (**B**) to the distribution of species contributing to functional categories (GO biological process terms), measuring their contributional diversities. The histograms show the mean alpha- (**A**) and beta-diversities (**B**) per GO term stratified by time windows. Colored shapes show (**A**) examples of pathways with different trends and (**B**) mean intra- and inter-subject beta-diversities of taxonomic profiles. **C-D** Species contributing to (**C**) siderophore biosynthetic process and (**D**) siderophore transport. Colors displaying the contributions of individual species are linearly scaled within the log-scaled total bar height depicting the total abundance of the pathway.](nihms-1512780-f0003){#F3}

###### DIABIMMUNE microbiome cohort statistics.

Distribution of study subjects, stool samples with sequencing data and several other external variables across the study sites. The table shows the number of study subjects (N) per category unless otherwise specified. T1D autoantibody and diagnosis information as of Nov. 2016.

                                                                      Finland      Estonia      Russia
  ------------------------------------------------------------------- ------------ ------------ ------------
  Study subjects                                                      140          80           73
  Samples profiled by 16S rRNA gene sequencing (median per subject)   2,080 (9)    501 (6)      623 (7)
  Samples profiled by metagenomic sequencing (median per subject)     616 (4)      221 (3)      317 (3)
  Males/Females                                                       78/62        39/41        40/33
  Caesarean sections                                                  9            6            12
  Mean maternal age at birth (sd)                                     31.1 (4.9)   29.1 (5.1)   27.8 (4.7)
  Born in rural household                                             10 (7.7%)    19 (23.8%)   0
  T1D AAB seropositive subjects                                       11           4            1
  Subjects with T1D diagnosis                                         5            1            1
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